NIAID Investigator-Initiated P01
Supports investigator-led infectious disease and immunology multi-project teams under NIAID.
PAR-27-082 is NIAID's standing Program Announcement with Special Receipt for investigator-initiated Program Project (P01) applications addressing the full scope of the National Institute of Allergy and Infectious Diseases mission. The announcement was posted May 7, 2026, last updated May 13, 2026, and remains open through May 25, 2029, with an archive date of July 24, 2029. Contact for applicants …
Biology and pathogenesis of infectious microbes (including HIV); host-microbe interactions; immune system regulation; immune dysfunction (allergy, asthma, autoimmunity, immunodeficiency, transplant rejection); translational research for vaccines, therapeutics, and diagnostics.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline